Close
The CASMI Fellowship offers an attractive opportunity for broader engagement with international academic and industrial colleagues with similar interest to develop innovative research projects.
CASMI represents an opportunity to showcase Fellows’ work, foster links to encourage interdisciplinary and interinstitutional research and scholarship, highlight and organise relevant meetings and influence policy and practice.
Becoming a CASMI Fellow offers an attractive opportunity for broader engagement with colleagues within related fields of work and interest.
- Expectations of CASMI Fellows
- Act as ambassadors for CASMI and to encourage broader engagement from colleagues wherever possible.
- Actively participate in discussions on the strategic direction of CASMI and its initiatives.
- Assist in developing working collaborations across UCL and other relevant institutions.
- Cite CASMI in publications or presentations on work done in collaboration with CASMI or on topics relevant to its agenda.
- Produce written material relevant to their field of expertise for inclusion on the CASMI website. This might include short reports of CASMI related work (e.g. ongoing research or implementation/development projects) they are engaged in for a section of the website that showcases ongoing projects.
- Contribute to CASMI education and training events.
- Benefits for CASMI fellows
- Preferential invitations to CASMI events and associated meetings.
- Potential discounted attendance at CASMI events.
- Membership of a network focussed on medical innovation that offers peer support and encourages new collaborations and opportunities for the development of research projects.
- Opportunity for participation in special commissions (e.g. Lancet series).
- Showcase their collaborative work through the CASMI website.
- Access to CASMI Members Site offering a range of tools/approaches and forum for discussion.
Current CASMI Fellows
- Dr Amanda Begley
Profile coming soon
- Professor Kay Davies
Profile coming soon
- Professor Andrew Farmer
Profile coming soon
- Professor Robert Horne
Profile coming soon
- Professor Michael Parker
Profile coming soon
- Professor Quentin Pankhurst
Profile coming soon
- Professor Rosalind Raine
Profile coming soon
- Professor Rachel Batterham
- Professor Rachel Batterham is Professor of Obesity, Diabetes and Endocrinology at University College London (UCL). She holds a prestigious National Institute of Health (NIHR) Research Professorship (2016-2021). She established and leads the University College London Hospital (UCLH) Bariatric Centre for Weight Management & Metabolic Surgery. She leads the UCL Centre for Obesity Research within the Department of Medicine and is the Director for the UCLH/UCL NIHR Biomedical Research Centre Obesity Research Theme.
Professor Batterham laboratory’s research is focused on increasing our understanding of body weight regulation and developing new therapies for the treatment of patients with obesity and type 2 diabetes. She has received several international awards including the Andre Mayer award from the World Obesity Federation (2016), the Diabetes UK Rank Fund Nutrition Prize (2015), the Lilly Scientific Achievement Award from The Obesity Society (2014), and the Linacre Medical from the Royal College of Physicians (2010).
Professor Batterham has made significant clinical contributions to defining the management of obese patients through her membership of the NICE Obesity Guideline Development Group and Royal College of Physicians Advisory Group on Health and Weight. Professor Batterham is currently a NICE Clinical Expert (2016-2021), Scientific Chair for the International Federation for Surgery for Obesity and Metabolic Diseases (IFSO) European Chapter (since 2015), a Trustee for the Association for the Study of Obesity (since 2016) and Council Member for British Obesity and Metabolic Surgery Society (since 2016).
- Professor Mark Cunningham
- Mark Cunningham is Professor of Neuronal Dynamics in the Institute of Neuroscience at Newcastle University and an Honorary Research Fellow position in Clinical Neurophysiology (Royal Victoria Infirmary, Newcastle NHS Trust).
He is a recognised expert in the application of electrophysiological techniques to study neuronal networks. His research focuses on understanding the generation of synchronised activity in brain networks of relevance to disorders including epilepsy and cognitive dysfunction. Mark sits on the Scientific Advisory Committee for Epilepsy Research UK, and has acted on advisory boards and as a consultant to numerous pharmaceutical companies.
- Christopher Exeter
- Christopher Exeter is a Director in the research group at UnitedHealth Group, where much of his work involves using data to re-engineer healthcare through research, innovation, prevention and patient empowerment. Recent work has involved research to understand public attitudes to data for health research – both formal (medical records) and informal (data from wearables, AI, for example).
Previously, he was a Fellow in the Department of Surgery & Cancer at Imperial College London, where his work focused on interventions to prevent non-communicable disease. He also developed an app to screen for blood pressure: the aim being for mass screening in public places in order to identify individuals with elevated blood pressure or at risk of hypertension. Prior to that, he was a civil servant at the Department of Health, where he held a number of policy roles.
- Professor Liam Grover
- Professor Liam Grover is a bio materials scientist, from the School of Chemical Engineering at the University of Birmingham, whose work has a strong focus on the development of novel medical technologies and their translation into the clinic. At present he is working on two projects that are focussed on moving protein-based pharmaceutics into use on the surface of the eye and skin (funded by Wellcome and MRC DPFS at a total values of £4.3m). He is also working with the military on therapies for the formation of pathological bone deposits and with the maxillofacial reconstruction department to reduce the rate of implant related infection. His strong track record in developing a translational pathway for these technologies has supported the University of Birmingham to fund the establishment of a research institute within the Institute for Translational Medicine at the University Hospital Birmingham, which focusses on the translation of Healthcare Technologies (Healthcare Technologies Research Institute – HTRI). Professor Grover would like to establish the HTRI as a leading light in the translation of medical technologies.
- Professor Alun David Hughes
- Alun Hughes is currently Professor of Cardiovascular Physiology and Pharmacology at UCL Institute of Cardiovascular Science. He is Head of the Department of Population Science & Experimental Medicine in the UCL Institute of Cardiovascular Science, and Associate Director of the MRC Unit for Lifelong Health and Ageing at UCL. He is also a visiting professor at the National Heart & Lung Institute, Imperial College London, the Menzies Institute for Medical Research, University of Tasmania & the Department of Pharmacology, University of Aarhus, Denmark.
Professor Hughes completed his medical degree (MB, BS) at St Mary's Hospital Medical School in 1983 having obtained a 1st class intercalated BSc degree in Physiology in 1979. He was awarded a PhD from the University of London in 1988 for his work on vascular dopamine receptors. Subsequently he was a Medical Research Council Training Fellow at St George's Hospital Medical School, a British Heart Foundation Intermediate Fellow, Senior Lecturer/Reader and subsequently Professor of Clinical Pharmacology at Imperial College London before moving to UCL.
Professor Hughes was Secretary of the British Hypertension Society from 2004 -2008, President of the European Council for Cardiovascular Research from 2008-2010, and is currently a faculty member and hononary Professor of the Danish Cardiovascular Research Academy (DaCRA).
- Professor Zisis Kozlakidis
- Dr Zisis Kozlakidis is a virologist, Chair of the Centre of Excellence in Infectious Diseases (BBMRI.uk); President of the International Society of Biological and Environmental Repositories (ISBER) and Faculty at the Cass Business School, City University teaching on Medical Leadership and Innovation. Zisis completed a PhD in Microbiology at Imperial College London followed by substantial working experience in the design of viral diagnostics. His expertise in viral diagnostics was acknowledged by being elected a Turnberg Fellow (2014), UK Academy of Medical Sciences and Fellow of the Linnean Society (2015), Royal Academy of Sciences.
Zisis has significant expertise in the archival preservation of viral species and biobanking. He is currently the President of ISBER and has provided operating feasibility advice on such facilities in a number of different countries including Germany, the USA, Saudi Arabia, Vietnam, Indonesia and China.
His current work overseen by the Department of Health at UCL involves the development and integration of next generation genomics in routine healthcare, and their associated financial impact(s) establishing their sustainability and long-term success. His contribution in the financial modelling of new healthcare operating models was recognized by the awarding of an Executive MBA degree by Cass Business School, City University (2015).
- Navin Ramachandran
Consultant Radiologist from UCLH and Honorary Senior Lecturer from UCL CHIME.
Full profile coming soon.
- Professor Anne Schilder
- Anne Schilder is an NIHR Research Professor at the UCL Ear Institute and Director of the NIHR UCLH BRC Deafness and Hearing Problems Theme. As joint Co-ordinating Editor of Cochrane ENT, National Lead of the NIHR Clinical Research Network ENT Specialty and Surgical Specialty Lead for ENT of the Royal College of Surgeon’s Clinical Trials Initiative, she plays a pivotal role in clinical research in ENT, Hearing and Balance in the UK.
Her current research focuses on hearing loss, a condition that affects one in six people in the UK and has a major impact on their physical, mental and social health. Hearing loss acquired in mid-life has recently been identified as a significant risk factor for dementia. Based on recent discoveries in the mechanisms of hearing loss, and supported by major public and private funds, a range of novel drug, gene and cell therapies are being developed to protect, restore and regenerate the hearing system. Anne’s research focuses on the translational aspects of applying these innovative hearing approaches in existing healthcare systems, and ranges from first-in-man trials, analysis of routine health data, to health economics and health policy.
Current hearing pathways do not meet the needs of people with hearing loss; there is variation and inequity in NHS hearing services, and current treatments, hearing aids, do not work well in natural (noisy) environments. My team works closely with patients, hearing scientists, clinicians and industry to develop and test novel hearing treatments and make sure that NHS patients will have access to these innovations.“
- Professor Andrew J Krentz
Profile coming soon
- Professor Andrew Dick
- Professor Andrew Dick qualified in medicine also with a degree in Biochemistry (BSc (Hons)) from the University of London, and during his medical education he also undertook an MRC research associate position in Biochemistry with Professor Coleman in Yale. Following training in internal medicine and MRCP he entered ophthalmology residency and obtained his postgraduate research degree in Immunology in 1993 at the University of Aberdeen. He underwent an MRC Post-Doctoral Fellowship to work with Jon Sedgwick at the Centenary Institute of Cancer Medicine and Cell Biology in Sydney Australia. His clinical expertise is in medical and surgical management of inflammatory disorders of the eye.
His research spans the basic and translational science conduit to early phase trials in inflammation as related to autoinflammatory, autoimmune and degenerative retinal disease. He has led pivotal experimental studies and clinical studies for the use of biologics and principally anti-TNF in ocular inflammatory diseases. The labs have been instrumental in the understanding of inflammatory cell kinetics during ocular inflammation in murine models, immune contribution to tissue damage and in particular macrophage biology and the control of macrophage activation and regulation of homeostasis.
Professor Dick is a Fellow of the Academy of Medical Sciences in the UK for his significant contribution to research and scholarship, in particular his development of molecular targets and biologic therapy for inflammatory eye disease and was awarded the Alcon Research Institute Research award in 2011.
Prior to becoming Director of institute of Ophthalmology, the UCL-Institute of Ophthalmology, he was Director of Research for the Faculty of Medicine and Dentistry at University of Bristol. He has previously been Editor of British Journal of Ophthalmology, President of European Vision and Eye Research (EVER), Master of Oxford Ophthalmological Congress and currently Vice-President of ARVO.
- Dr Jo Gibbs
Profile coming soon
- Dr Xiao Liu
- Dr Xiao Liu received the Ph.D. degree from University College London (UCL), London, U.K. He is currently a Lecturer with the Department of Electronic and Electrical Engineering, UCL. His group works on analogue and mixed-signal circuit design for biomedical applications, neuroprostheses, microelectronic sensors, microsystems and wearable technologies. Several of his devices has gone through animal tests and are now in the phase of clinical trial. His patented sensor technology on adherence monitoring for inhaled therapy has been commercialized to industry.
Dr Liu holds a UKRI Innovation Fellowship awarded by the UK Engineering and Physical Science Research Council (EPSRC). He is an Associate Editor for the IEEE TRANSACTIONS ON CIRCUITS AND SYSTEMS I: REGULAR PAPERS. He is a Chartered Engineer and a member of the Biomedical and Life Science Circuits and Systems Technical Committee of the IEEE Circuits and Systems Society.
Dr Liu’s research interests:
Custom microchips for biomedical applications, lab on a chip and point-of-care devices, microelectronic sensors and microsystems and wearable technologies.
Collaborative interest areas:
Implanted devices and microsystems for neurologically impaired patients, drug delivery, wireless sensing and wearable technologies for both medical and consumer applications.
- Professor Nikhil Sharma
Profile coming soon
- Professor Geraint Thomas
Profile coming soon
- Dr Stuart Faulkner
Profile coming soon
- Professor Richard Barker
Profile coming soon
- Dr Suzanne Li
Profile coming soon
- Dr Liz Morrell
Profile coming soon
- Dr Elin Haf Davies
Profile coming soon
- Professor Nick Fahy
Profile coming soon
- Dr Stuart Calimport
- Dr Stuart Calimport is an Honorary Fellow of the University of Liverpool, Department of Musculoskeletal Biology II and a CASMI Fellow. Stuart has a PhD in Biomedical Sciences from Aston University, an MPhil in Biosciences from Newcastle University, an MSc in Molecular Medicine from Imperial College London, an MA in Practical Ethics: Bioethics, Environmental Ethics and the Foundations of Law from The University of York and a BSc in Bioinformatics from the University of Birmingham.
Stuart specialises in the systematic and comprehensive classification and staging of ageing damage, frailty and disease, and associated metabolic diseases, to drive the translation of novel disease codes and staging to deliver real world patient outcomes via the World Health Organization International Classification of Diseases.
Stuart divides his time between academic work, policy and regulatory work, and industry. His collaborative areas of interest include development of disease classifications, disease staging and diagnostic criteria relating to ageing damage, frailty and disease and their clinical translation. He is also interested in the public health and healthcare economic impact from a systematic and comprehensive disease classification and staging of ageing damage, frailty and disease in relation to preventative medicine and multi-morbidity reversal.
- Mr Adam James
Profile coming soon.
